Last reviewed · How we verify
NCT05060185
The Flow Diverter for Treating Patients With Intracranial Aneurysms
NA trial testing the Flow Diverter in Intracranial Aneurysm in 166 participants. Status unknown.
28 February 2024
Quick facts
| Lead sponsor | Jiangsu CED Medtech Co., Ltd |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 166 |
| Start date | 17 October 2021 |
| Primary completion | 28 February 2024 |
| Estimated completion | 31 May 2024 |
Drugs / interventions tested
- the Flow Diverter
Conditions studied
- Intracranial Aneurysm — all drugs for Intracranial Aneurysm →
Sponsor
Jiangsu CED Medtech Co., Ltd
Who can join
Adults 18 to 75, any sex, with Intracranial Aneurysm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the efficacy and safety of the blood flow guide device manufactured by Jiangsu Changyida Medical Technology Co., Ltd. for endovascular embolization of intracranial aneurysms
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05060185
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intracranial Aneurysm
Currently open trials in the same condition.
- NCT07123818 — AI for Detection of Brain Aneurysm: Low-cost Opportunistic Screening · NA · active not recruiting
- NCT06494436 — Microvention AnEurysm & STroke Real-life Data cOllection · recruiting
- NCT06588543 — Patient-specific Planning of Minimally Invasive Brain Interventions Based on Vascular-hemodynamic Mapping · recruiting
- NCT05831202 — SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial · Phase 3 · active not recruiting
- NCT06416657 — General Anesthesia vs Local Anesthesia for Endovascular Treatment in Patients With Unruptured Intracranial Aneurysm Usin · NA · recruiting
Other Jiangsu CED Medtech Co., Ltd trials
Trials by the same sponsor.
- NCT06485492 — Aneurysm Embolization System for Intracranial Aneurysms · NA · not yet recruiting
- NCT06494956 — To Evaluate the Safety of DBS in Patients With Primary Parkinson's Disease · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05060185 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jiangsu CED Medtech Co., Ltd
- Last refreshed: 29 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05060185.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing